TrialPloS one2013

KIR, HLA, and IL28B variant predict response to antiviral therapy in genotype 1 chronic hepatitis C patients in Japan.

Yuichi Nozawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.